Bioasis Technologies Stock Fundamentals
| BTI Stock | CAD 0.01 1.25 99.60% |
biOasis Technologies fundamentals help investors to digest information that contributes to British Amer's financial success or failures. It also enables traders to predict the movement of British Stock. The fundamental analysis module provides a way to measure British Amer's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to British Amer stock.
At this time, British Amer's Total Other Income Expense Net is fairly stable compared to the past year. Interest Expense is likely to climb to about 90.1 K in 2024, whereas Operating Income is likely to drop (4.9 M) in 2024. British | Select Account or Indicator |
biOasis Technologies Company Shares Outstanding Analysis
British Amer's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current British Amer Shares Outstanding | 79.41 M |
Most of British Amer's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, biOasis Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
British Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for British Amer is extremely important. It helps to project a fair market value of British Stock properly, considering its historical fundamentals such as Shares Outstanding. Since British Amer's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of British Amer's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of British Amer's interrelated accounts and indicators.
Click cells to compare fundamentals
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
British Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, biOasis Technologies has 79.41 M of shares currently outstending. This is 56.01% lower than that of the Biotechnology sector and 25.68% lower than that of the Health Care industry. The shares outstanding for all Canada stocks is 86.11% higher than that of the company.
biOasis Technologies Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining British Amer's current stock value. Our valuation model uses many indicators to compare British Amer value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across British Amer competition to find correlations between indicators driving British Amer's intrinsic value. More Info.biOasis Technologies is number one stock in return on asset category among its peers. It also is number one stock in operating margin category among its peers . At this time, British Amer's Operating Profit Margin is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the British Amer's earnings, one of the primary drivers of an investment's value.British Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses British Amer's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of British Amer could also be used in its relative valuation, which is a method of valuing British Amer by comparing valuation metrics of similar companies.British Amer is currently under evaluation in shares outstanding category among its peers.
British Fundamentals
| Return On Asset | -0.81 | ||||
| Operating Margin | (4.69) % | ||||
| Current Valuation | 2.45 M | ||||
| Shares Outstanding | 79.41 M | ||||
| Shares Owned By Insiders | 2.05 % | ||||
| Number Of Shares Shorted | 105.04 K | ||||
| Price To Earning | 25.91 X | ||||
| Price To Book | 54.04 X | ||||
| Price To Sales | 1.47 X | ||||
| Revenue | 269.38 K | ||||
| Gross Profit | (1.19 M) | ||||
| EBITDA | (2.98 M) | ||||
| Net Income | (2.96 M) | ||||
| Cash And Equivalents | 2.68 M | ||||
| Cash Per Share | 0.04 X | ||||
| Total Debt | 1.9 M | ||||
| Debt To Equity | 0.31 % | ||||
| Current Ratio | 1.70 X | ||||
| Book Value Per Share | (0.03) X | ||||
| Cash Flow From Operations | (3.64 M) | ||||
| Short Ratio | 0.01 X | ||||
| Earnings Per Share | (0.04) X | ||||
| Target Price | 2.0 | ||||
| Beta | 0.52 | ||||
| Market Capitalization | 397.07 K | ||||
| Total Asset | 2.27 M | ||||
| Retained Earnings | (40.65 M) | ||||
| Working Capital | (882.74 K) | ||||
| Net Asset | 2.27 M |
About British Amer Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze biOasis Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of British Amer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of biOasis Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 129.3 K | 201.9 K | |
| Total Revenue | 697.3 K | 930.9 K | |
| Stock Based Compensation To Revenue | 0.84 | 0.80 | |
| Sales General And Administrative To Revenue | 4.71 | 4.48 | |
| Research And Ddevelopement To Revenue | 3.02 | 4.91 | |
| Capex To Revenue | 0.01 | 0.01 | |
| Revenue Per Share | 0.01 | 0.01 | |
| Ebit Per Revenue | (9.85) | (10.34) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for British Stock Analysis
When running British Amer's price analysis, check to measure British Amer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy British Amer is operating at the current time. Most of British Amer's value examination focuses on studying past and present price action to predict the probability of British Amer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move British Amer's price. Additionally, you may evaluate how the addition of British Amer to your portfolios can decrease your overall portfolio volatility.